CONNECT WITH US
HealthTech

HealthTech

Siemens Healthineers to stop selling general ultrasound systems

MedTech Dive logo

Published on

Add as a preferred source on Google
Siemens Healthineers to stop selling general ultrasound systems

In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries.

Siemens Healthineers said Monday that it will no longer sell general imaging ultrasound systems , focusing instead on ultrasound used in procedural imaging.

The company will focus on systems used in interventional cardiology and electrophysiology procedures. Siemens Healthineers said this approach will allow it to bring together its imaging systems, software capabilities and partnerships with heart device companies to support physicians in increasingly complex procedures.

Siemens Healthineers said it will continue to provide support for its general ultrasound systems, including maintenance, software updates and transducer availability.

Siemens Healthineers last year debuted a new strategy to focus on using artificial intelligence and partnerships to tackle four prevalent diseases: stroke, cancer, cardiovascular and neurovascular conditions.

The company’s latest changes contribute to that effort. Noting that general imaging ultrasound is well served, with multiple established companies, Siemens Healthineers said it plans to focus on image-guided cardiovascular therapy. One of the modalities the company is emphasizing is intracardiac echocardiography, a technique where an ultrasound-tipped catheter is passed into the heart.

Siemens Healthineers plans to offer its Acuson Origin cardiovascular imaging platform, which received Food and Drug Administration clearance in 2024. The system includes AI features to help with measurements and view recognition. The company will also continue to sell its Acuson Freestyle wireless ultrasound system and its P500 portable ultrasound machine.

Siemens Healthineers said it would discontinue sales of general ultrasound systems including its Acuson Sequoia, Redwood, Juniper and Maple brands.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.